Infection and Immunity · 2006 · 34 citations · 40 references
Life SciencesBiochemistryPharmacologyGlycobiologyLipid BiochemistryMechanisms Of ToxicityEnzyme InhibitionGlycan AnalysisGlycan StructureLipid MetabolismMechanisms Of Toxic InjuryMolecular Mechanisms Of ToxicityAntimalarial AgentsFatty AcidsImmunopathology Of MalariaInflammatory Cytokine ProductionMalaria ImmunologyMalaria PathologyPlasmodium FalciparumTumor Necrosis Factor Regulation
Plasmodium falciparum malaria kills roughly 2.5 million people, mainly children, annually. Much of this mortality is thought to arise from the actions of a malarial toxin. This toxin, identified as glycosylphosphatidylinositol (GPI), is a major pathogenicity determinant in malaria. A malarial molecule, Pfj, labeled by [3H]glucosamine like the GPIs, was identified as a non-GPI molecule. Here we show that Pfj is able to down-regulate tumor necrosis factor alpha (TNF-alpha) production induced by the GPI of P. falciparum. Mass spectrometry analysis showed that Pfj was not a single molecule but represented a number of molecules. Separation methods, such as cation-exchange chromatography and thin-layer chromatography, were used to isolate and identify the following four main fatty acids responsible for the inhibitory effect on TNF-alpha production: myristic, pentadecanoic, palmitic, and palmitoleic acids. This regulatory effect on cytokine production suggests that there is balanced bioactivity for the different categories of malarial lipids.
40
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
Louis Schofield, Michael C. Hewitt, Krystal J. Evans et al. · Nature · 2002 · 485 citations